ATE302011T1 - PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN - Google Patents
PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGENInfo
- Publication number
- ATE302011T1 ATE302011T1 AT99968140T AT99968140T ATE302011T1 AT E302011 T1 ATE302011 T1 AT E302011T1 AT 99968140 T AT99968140 T AT 99968140T AT 99968140 T AT99968140 T AT 99968140T AT E302011 T1 ATE302011 T1 AT E302011T1
- Authority
- AT
- Austria
- Prior art keywords
- ponazuril
- abortigenics
- coccidia
- neurological
- treatment
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003508 ponazuril Drugs 0.000 title abstract 2
- 241000224483 Coccidia Species 0.000 title 1
- 230000000926 neurological effect Effects 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 201000005485 Toxoplasmosis Diseases 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- -1 triazineone compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/218,323 US6150361A (en) | 1998-12-22 | 1998-12-22 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| PCT/US1999/030281 WO2000037063A2 (en) | 1998-12-22 | 1999-12-18 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302011T1 true ATE302011T1 (de) | 2005-09-15 |
Family
ID=22814646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99968140T ATE302011T1 (de) | 1998-12-22 | 1999-12-18 | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6150361A (de) |
| EP (1) | EP1140103B1 (de) |
| JP (1) | JP2002532544A (de) |
| KR (1) | KR100661111B1 (de) |
| CN (1) | CN1221265C (de) |
| AT (1) | ATE302011T1 (de) |
| AU (1) | AU764608B2 (de) |
| BR (1) | BR9916391A (de) |
| CA (1) | CA2355825C (de) |
| DE (1) | DE69926794T2 (de) |
| DK (1) | DK1140103T3 (de) |
| ES (1) | ES2247863T3 (de) |
| HK (1) | HK1045266B (de) |
| HU (1) | HUP0104595A3 (de) |
| NZ (1) | NZ512477A (de) |
| WO (1) | WO2000037063A2 (de) |
| ZA (1) | ZA200103920B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1043019B (zh) | 1998-10-08 | 2005-05-13 | 高新研究公司 | 用於预防和治疗原虫病的组合物和方法 |
| DE19958388A1 (de) * | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten |
| BR0110232A (pt) * | 2000-04-25 | 2003-01-21 | Wyeth Corp | Vacina para mioencefalite equina causada por protozoário |
| DE10040174A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
| DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
| DE102006038292A1 (de) * | 2006-08-16 | 2008-02-21 | Bayer Healthcare Ag | Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen |
| DE102007025908A1 (de) | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
| DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
| WO2024138230A1 (en) * | 2022-12-02 | 2024-06-27 | Veterinary Pharmacy Corporation | Formulation and method for treatment of infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2718799A1 (de) * | 1977-04-27 | 1978-11-09 | Bayer Ag | 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer |
| US4933341A (en) * | 1988-10-08 | 1990-06-12 | Bayer Aktiengesellschaft | Substituted 1,3,5-triazinetriones, for use against parasitic protozoa |
| US5883095A (en) * | 1997-08-07 | 1999-03-16 | University Of Kentucky Research Foundation | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
| WO1998043644A1 (en) * | 1997-03-31 | 1998-10-08 | David Granstrom | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
| DE19824483A1 (de) * | 1998-06-02 | 1999-12-09 | Bayer Ag | Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon |
| HK1043019B (zh) * | 1998-10-08 | 2005-05-13 | 高新研究公司 | 用於预防和治疗原虫病的组合物和方法 |
-
1998
- 1998-12-22 US US09/218,323 patent/US6150361A/en not_active Expired - Fee Related
-
1999
- 1999-12-18 JP JP2000589174A patent/JP2002532544A/ja not_active Withdrawn
- 1999-12-18 ES ES99968140T patent/ES2247863T3/es not_active Expired - Lifetime
- 1999-12-18 DK DK99968140T patent/DK1140103T3/da active
- 1999-12-18 WO PCT/US1999/030281 patent/WO2000037063A2/en not_active Ceased
- 1999-12-18 DE DE69926794T patent/DE69926794T2/de not_active Expired - Lifetime
- 1999-12-18 NZ NZ512477A patent/NZ512477A/en not_active IP Right Cessation
- 1999-12-18 AU AU24817/00A patent/AU764608B2/en not_active Ceased
- 1999-12-18 KR KR1020017006549A patent/KR100661111B1/ko not_active Expired - Fee Related
- 1999-12-18 HU HU0104595A patent/HUP0104595A3/hu unknown
- 1999-12-18 CN CNB998148342A patent/CN1221265C/zh not_active Expired - Fee Related
- 1999-12-18 EP EP99968140A patent/EP1140103B1/de not_active Expired - Lifetime
- 1999-12-18 AT AT99968140T patent/ATE302011T1/de not_active IP Right Cessation
- 1999-12-18 CA CA002355825A patent/CA2355825C/en not_active Expired - Fee Related
- 1999-12-18 HK HK02106846.1A patent/HK1045266B/zh not_active IP Right Cessation
- 1999-12-18 BR BR9916391-8A patent/BR9916391A/pt not_active Application Discontinuation
-
2001
- 2001-05-15 ZA ZA200103920A patent/ZA200103920B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0104595A3 (en) | 2003-10-28 |
| KR100661111B1 (ko) | 2006-12-26 |
| US6150361A (en) | 2000-11-21 |
| EP1140103A2 (de) | 2001-10-10 |
| AU764608B2 (en) | 2003-08-28 |
| AU2481700A (en) | 2000-07-12 |
| DE69926794T2 (de) | 2006-01-19 |
| ES2247863T3 (es) | 2006-03-01 |
| WO2000037063A2 (en) | 2000-06-29 |
| EP1140103B1 (de) | 2005-08-17 |
| ZA200103920B (en) | 2002-05-15 |
| WO2000037063A3 (en) | 2000-10-19 |
| NZ512477A (en) | 2004-05-28 |
| CA2355825C (en) | 2008-07-08 |
| CN1221265C (zh) | 2005-10-05 |
| DK1140103T3 (da) | 2005-12-19 |
| JP2002532544A (ja) | 2002-10-02 |
| HK1045266A1 (en) | 2002-11-22 |
| HK1045266B (zh) | 2006-07-07 |
| HUP0104595A2 (hu) | 2002-04-29 |
| CN1342081A (zh) | 2002-03-27 |
| CA2355825A1 (en) | 2000-06-29 |
| DE69926794D1 (de) | 2005-09-22 |
| KR20010080570A (ko) | 2001-08-22 |
| BR9916391A (pt) | 2001-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| EA200701296A1 (ru) | 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства | |
| DE60331537D1 (de) | Kombinationen zur behandlung von multiplem myelom | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| EA200601281A1 (ru) | Азабензофуранзамещенные тиомочевины; ингибиторы репликации вирусов | |
| ATE399782T1 (de) | Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen | |
| ATE416164T1 (de) | Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| ATE270891T1 (de) | Triazinoneverbindungen für die behhandlung von krankheiten verursacht durch neospora und toxoplasma | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| EE9900275A (et) | CD40L-vastaste ühendite terapeutilise manustamise meetodid | |
| ATE302011T1 (de) | PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN | |
| EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
| MXPA06014182A (es) | Nucleosidos de 3-??-d-ribofuranosiltiazolo[4,5-d]piridimina y usos de los mismos. | |
| DE69300321D1 (de) | Behandlung neurodegenerativer Erkrankungen. | |
| BR9916417A (pt) | Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma | |
| DE60108130D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten | |
| EP1050303A3 (de) | Methoden und Zusammenstellungen zur Behandlung von altersgebundenen Verhaltensstörungen von Haustieren | |
| DE60115237D1 (de) | Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien | |
| ATE248607T1 (de) | Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen | |
| EA200200846A1 (ru) | Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором | |
| UA91697C2 (en) | 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF | |
| MX9704887A (es) | Composiciones farmaceuticas para el tratamiento de trastornos depresivos. | |
| RU93036230A (ru) | Способ лечения больных бронхиальной астмой |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1140103 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |